BioRestorative Therapies, Inc.
BRTX
BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtxDisc) includes a lead cell therapy candidate, BRTX-10ā¦ read more
Healthcare
Biotechnology
13 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$1.18
Price+0.43%
$0.00
1Y
Price
Market Cap
$10.054m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-25302.2%
EBITDA Margin-25748.1%
Net Profit Margin-24585.9%
Free Cash Flow Margin-25302.2%
EBITDA Margin-25748.1%
Net Profit Margin-24585.9%
Free Cash Flow MarginRevenue
$383.400k
-4.4%
1y CAGR+64.1%
3y CAGR+88.2%
5y CAGREarnings
-$12.670m
-41.1%
1y CAGR-2.0%
3y CAGR+16.0%
5y CAGREPS
-$1.48
-27.6%
1y CAGR+19.3%
3y CAGR+37.0%
5y CAGRBook Value
$2.207m
$5.643m
Assets$3.436m
Liabilities-
DebtDebt to Assets
0.0%
-
Debt to EBITDAFree Cash Flow
-$10.770m
-29.2%
1y CAGR-19.8%
3y CAGR-37.1%
5y CAGRNo items found.
Press Releases
Statements and updates from the company